British Columbia Issues Multiple Toxic Drug Warnings as Counterfeit Pills and Powerful Opioids Raise Overdose Concerns

BRITISH COLUMBIA, CANADA: Health authorities in British Columbia are warning residents about an increasingly dangerous unregulated drug supply after several toxic drug alerts were issued across the province’s Interior region, including warnings about counterfeit prescription pills containing powerful synthetic opioids.

Interior Health has identified potentially life-threatening substances circulating in communities including Kamloops, Cranbrook and the Kootenays, raising concerns about accidental overdoses and the growing difficulty of identifying dangerous drugs.

The warnings come as British Columbia continues to confront a prolonged toxic drug crisis that has claimed thousands of lives over the past decade.

Health officials say some substances being sold on the illicit market contain unexpected combinations of opioids, benzodiazepines and veterinary tranquilizers, creating serious risks for people who may not know what they are consuming.

One of the most alarming developments involves counterfeit tablets marketed as the prescription painkiller Dilaudid. Testing has revealed that some of these pills contain isotonitazene, an extremely potent synthetic opioid, instead of the medication’s expected active ingredient, hydromorphone.

The discovery has prompted urgent warnings because the counterfeit tablets can closely resemble legitimate pharmaceutical products, making them difficult to distinguish through appearance alone.

Antoine Marcheterre, who leads drug checking operations for Interior Health, warned that the fake pills can be significantly more potent than the medications they imitate.

According to health officials, the substances found in these counterfeit tablets can create a substantially greater overdose risk than users might anticipate.

The Kamloops warning, issued on October 22, highlighted the danger of pills that appear to be familiar prescription medications but contain entirely different chemical compounds.

Such counterfeit products pose a particular threat because people may assume they know the strength and effects of a tablet based on its appearance.

Health authorities stress that visual inspection cannot reliably determine whether an unregulated pill contains the substance advertised by its seller.

The presence of isotonitazene is especially concerning because it belongs to a group of powerful synthetic opioids known as nitazenes, some of which can be considerably stronger than fentanyl.

These substances can cause severe respiratory depression, unconsciousness and fatal overdose, particularly when taken without knowledge of their actual contents.

The danger increases further when potent opioids are combined with other sedating drugs.

In Cranbrook, Interior Health issued another alert on October 27 after testing substances being sold under names such as down, dope, tranq and fentanyl.

The samples contained fentanyl analogues alongside benzodiazepines and other tranquilizing substances.

Fentanyl analogues are synthetic opioids chemically related to fentanyl, although their potency and effects can vary significantly.

The combination of these substances can produce profound sedation and create complex medical emergencies.

Interior Health specifically warned about mixtures containing medetomidine, ethylflualprazolam and fentanyl analogues.

Medetomidine is a powerful sedative used in veterinary medicine, while ethylflualprazolam belongs to the benzodiazepine family of drugs.

When these substances are combined with opioids, they can increase the risk of severe sedation, impaired breathing and prolonged unconsciousness.

The health authority cautioned that some sedative effects may continue even after naloxone has been administered.

Naloxone is an emergency medication capable of reversing the effects of opioid overdoses, but it does not directly reverse sedation caused by benzodiazepines or other non-opioid tranquilizers.

Health officials nevertheless emphasize that naloxone remains essential whenever an opioid overdose is suspected, even if other substances may also be present.

Emergency medical assistance is particularly important when someone remains unconscious or has difficulty breathing after naloxone is given.

The Cranbrook alert followed similar warnings issued elsewhere in the region earlier in October.

On October 19, Interior Health reported dangerous combinations of fentanyl analogues, medetomidine and several benzodiazepines in substances circulating in the Kootenays.

The repeated discoveries suggest that highly unpredictable drug mixtures are appearing in multiple communities rather than being confined to a single location.

The situation has created additional challenges for healthcare workers, emergency responders and harm reduction organizations attempting to prevent fatal overdoses.

At the same time, police in Salmon Arm issued a separate public warning after responding to two suspected overdoses within a 24-hour period.

The RCMP said the specific substance involved had not yet been identified, but urged people who use unregulated drugs to take precautions and avoid being alone.

The incidents reinforced concerns that dangerous substances may be circulating without immediate confirmation of their chemical composition.

The uncertainty surrounding the drug supply means individuals may unknowingly consume substances that differ significantly from what they intended to obtain.

Health officials say this unpredictability is one of the most serious features of the current toxic drug crisis.

Unlike regulated pharmaceutical medications, illicitly manufactured substances do not undergo consistent quality control, and their ingredients and potency can vary considerably.

Even products sold under the same name may contain different combinations of drugs.

As a result, a person who has previously used a particular substance without experiencing an overdose may face a much greater risk when obtaining another batch.

Drug checking services have become an important part of British Columbia’s efforts to identify dangerous substances and provide timely public warnings.

These services allow samples to be analyzed for unexpected ingredients, helping people better understand the potential risks associated with the unregulated supply.

However, health authorities acknowledge that drug testing cannot eliminate every danger, particularly when substances contain multiple powerful compounds.

Interior Health continues to recommend using overdose prevention services where available, avoiding drug use alone and keeping naloxone accessible.

The authority also encourages people to seek information about local drug checking services.

The latest alerts arrive against the backdrop of a continuing public health emergency in British Columbia.

The province declared toxic drug deaths a public health emergency in 2016, yet the crisis remains a major concern for families, healthcare providers and communities.

According to the latest figures from the B.C. Coroners Service, 177 deaths linked to the unregulated drug supply were recorded in the Interior Health region during the first eight months of 2026.

The region recorded 321 such deaths throughout 2025.

Although the current year’s figures cover only January through August and cannot be directly compared with a complete previous year, they demonstrate the continuing human cost of the toxic drug crisis.

Every fatal overdose represents a devastating loss for families and communities, while non-fatal overdoses can also result in serious health complications.

The spread of counterfeit prescription pills adds another layer of concern because the danger is not limited to substances openly marketed as illicit opioids.

People purchasing tablets they believe to be pharmaceutical painkillers may be exposed to exceptionally powerful synthetic compounds without their knowledge.

Health experts warn that counterfeit medications can be particularly dangerous for individuals who have little or no opioid tolerance.

The appearance of increasingly potent synthetic opioids has also complicated emergency responses, sometimes requiring repeated naloxone administration and immediate medical care.

At the same time, the presence of tranquilizers that do not respond to naloxone can prolong unconsciousness and increase the need for professional medical intervention.

These developments highlight the importance of rapid public alerts, accessible drug checking and effective emergency response systems.

They also demonstrate the challenges facing British Columbia as authorities attempt to reduce overdose deaths while addressing the broader social and health consequences of the unregulated drug market.

For communities across the Interior, the recent warnings serve as a reminder that the toxic drug crisis remains active and unpredictable.

The discoveries in Kamloops, Cranbrook and the Kootenays have shown that dangerous substances can be distributed under familiar names, including those associated with prescription medications.

Health officials are urging residents to take the warnings seriously, recognize the signs of an overdose and seek emergency assistance when someone becomes unresponsive or experiences breathing difficulties.

As British Columbia continues working to prevent further deaths, the latest alerts underline the urgent need for public awareness, effective harm reduction measures and coordinated healthcare responses.

With powerful synthetic opioids, counterfeit pills and unexpected sedatives appearing in the drug supply, authorities warn that knowing what a substance is called or how it looks is no guarantee of its safety.

The continuing crisis remains a significant public health challenge for British Columbia, requiring sustained attention from governments, healthcare professionals and communities determined to prevent further loss of life.

Courtesy: CBC